Molecular Biomarkers of Response to Radiation Therapy in Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-75
SponsorInstitute of Oncology Ljubljana
About this trial
The purpose of this study is to identify potential genetic and other molecular biomarkers of response to radiation therapy in breast cancer that may help to personalize breast cancer radiation treatment in the future.
Eligibility criteria
Qualifiers
Breast cancer patients with DCIS with an indication for adjuvant radiation therapy
Disqualifiers
Any specific systemic oncological therapy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Institute of Oncology Ljubljana
Lead sponsor
University of Ljubljana, Faculty of Medicine
Collaborator
University Medical Centre Ljubljana
Collaborator
Source ClinicalTrials.gov